JACIE: A 20 year-old voluntary body functioning worldwide

Area of Science:

• Hematology
• Immunotherapy
• Cellular Therapy

Background:

• Hematopoietic Stem Cell Transplantation (HSCT) is a critical treatment for severe blood disorders, pioneered in 1957.
• While HSCT numbers have risen globally, quality improvement has lagged behind volume increases.
• The European Group for Bone Marrow Transplantation (EBMT) and SHAGE Europe established initial standards in 1998.

Purpose of the Study:

• To review the aims and twenty-year history of the Joint Accreditation Committee of ISCT-EBMT (JACIE).
• To highlight JACIE's role in improving HSCT quality worldwide and specifically in Turkey.
• To inform stakeholders, including patients, about JACIE's contributions to HSCT standards.

Main Methods:

• Review of historical data and establishment of HSCT standards.
• Analysis of JACIE's organizational development and impact over two decades.
• Examination of JACIE's implementation and history in Turkey.

Main Results:

• JACIE was founded to enhance HSCT quality and patient safety.
• The organization has played a vital role in standardizing cell collection, processing, and transplantation.
• Significant progress in HSCT quality has been observed over the past twenty years due to JACIE's efforts.

Conclusions:

• JACIE is essential for maintaining and improving HSCT standards globally.
• The committee's work benefits all stakeholders, particularly patients undergoing HSCT.
• The review underscores the importance of accreditation in advancing cellular therapies.